Compound name
BAY-299
Protein family
Bromodomain
Target name
BRD1@BRD
Affinity biochemical (nM)
67
Affinity on-target cellular (nM)
503
CG-Set
Epigenetic set
Recommended Concentration
1 µM
Compound EUbOPEN ID
EUB0000191c
SMILES
Cc1cc2c(cc1N1C(=O)c3cccc4c(CCCO)ccc(c34)C1=O)n(C)c(=O)n2C
InChIKey
OFWWWKWUCDUISA-UHFFFAOYSA-N
NCBI gene ID
23774
UniProt ID
O95696
Synonyms
BRL, BRPF2
Mode of action
Inhibitor
Negative control
BAY-364
Affinity biochemical definition
IC50
Affinity biochemical assay type
TR-FRET assay
Affinity Biochemical Source Knowledge
https://doi.org/10.1021/acs.jmedchem.7b00306
Affinity biochemical relation
=
Affinity on-target cellular definition
IC50
Affinity on-target cellular assay type
NanoBRET assay (HEK293T cells)
Affinity on-target cellular relation
=
Selectivity platform
CEREP panel (LeadProfilingScreen Eurofins)
Selectivity platform number of targets
68
Selectivity remarks
Screened at 10 µM against receptors, ion channels and enzymes, closest targets as % of contr.: A1 receptor (48%), Cl- channel (GABA-gated) (23%), PDE2A1 (49%), PDE5 (2%), >10000-fold selective; In vitro activity of closest targets (TR-FRET assays): IC50(BRPF1) = 3.15 µM, IC50(BRPF3) = 5.55 µM, IC50(TAF1L, BD2) = 0.106 µM, IC50(BRD4, BD1) >15 µM, IC50(BRD4,BD2) >20 µM; Screened in DSF assay against 48 bromodomains at 10 µM, closest targets: dTm(CECR2) = 3.5 K, dTm(EP300) = 3.5 K, dTm(BRD7) = 2.3 K; In vitro follow up ITC: Kd(CECR2) = 1.39 µM; Screened against31 bromodomains in (BROMOscan DiscoverX) at 100 nM, closest targets as % contr.: CREBBP (30%), TAF1L(BD2) (0.7%); Screened against 300 kinases at 10 µM, >10000-fold selective (PMID: 28402630)
Selectivity Source Knowledge
https://doi.org/10.1021/acs.jmedchem.7b00306
https://www.thesgc.org/chemical-probes/BAY-299
Selectivity Number of Off-targets
0